Drug Facts Panel for Sunscreens: Getting Bemotrizinol Labeling Right

When an international sunscreen fails to make it onto a U.S. shelf, the label is usually the culprit. In the United States, sunscreens are OTC drugs, meaning they must adhere to a strict, standardized format known as the Drug Facts panel. This format looks nothing like a typical cosmetic label. Here's what it requires and where bemotrizinol products often go wrong.

What the Drug Facts Panel Must Contain

The Drug Facts panel follows a fixed order and specific wording. At a minimum, it covers:

• Active ingredient(s) — This includes bemotrizinol and its concentration (up to 6%), along with its purpose.

• Purpose — For example, sunscreen.

• Uses — The permitted use statements for sunscreens.

• Warnings — This includes required warnings about skin cancer, skin aging, and other monograph warnings.

• Directions — Instructions for application and reapplication.

• Other information — This includes inactive ingredients.

  
  

Claims You Can and Can't Make

Your SPF value, broad-spectrum designation, and any water-resistance claim must each be supported by testing on the final formulation, following the monograph's methods. Claims that exceed the data or use language not permitted by the monograph can quickly lead to misbranding issues.

Common Labeling Errors with Bemotrizinol Products

The recurring errors in bemotrizinol labels are predictable. Common mistakes include:

• A home-market layout that hasn't been converted to the Drug Facts format.

• An active ingredient declaration that does not match the formulation.

• SPF or broad-spectrum claims lacking corresponding test reports.

• Missing or reworded mandatory warnings.

  
  

Each of these issues is fixable before launch, and it is far more cost-effective to address them early in the process.

Importance of Pre-Launch Label Review

A label review against the Drug Facts format and your supporting tests is one of the most impactful steps you can take before launching your product. Unfortunately, this is often the step brands skip, leading to costly mistakes.

Get the Checklist

Labeling is one section of our Bemotrizinol (BEMT) U.S. Market-Entry Compliance Checklist. Download the free checklist → Or have Axentra review your label directly as part of the U.S. Market Entry Package.

---

Frequently Asked Questions

Can I Keep My Existing International Sunscreen Label for the U.S.?

Almost never as-is. U.S. sunscreens require a Drug Facts panel in a specific format, so most international labels need to be rebuilt.

Does My SPF Claim Need U.S. Testing?

Yes, your SPF, broad-spectrum, and water-resistance claims must be supported by testing on the final formulation, following the monograph's methods.

What Happens If My Label Isn't Compliant?

A non-compliant label can render the product misbranded. This misbranding can lead to detention, refusal, or enforcement action.

Understanding the Regulatory Landscape

Navigating the U.S. regulatory landscape can be complex. It's essential to understand the specific requirements for labeling and testing. This knowledge will help you avoid common pitfalls and ensure compliance with FDA regulations.

The Role of a U.S. Agent

Having a legally designated U.S. Agent is crucial for foreign companies looking to enter the U.S. market. This agent acts as a liaison between your company and the FDA. They can assist with facility registration, product listings, and ongoing compliance support.

Facility Registration and Compliance

Before you can market your sunscreen in the U.S., you must register your facility with the FDA. This registration is a vital step in the compliance process. It ensures that your manufacturing practices meet U.S. standards.

Importance of Ongoing Compliance Support

Once your product is on the market, ongoing compliance support is necessary. Regulations can change, and staying informed is key to maintaining your product's marketability. Regular reviews of your labeling and claims will help you stay compliant.

Conclusion

In summary, understanding the requirements for sunscreen labeling in the U.S. is essential for successful market entry. By ensuring that your Drug Facts panel is compliant and that all claims are substantiated, you can avoid costly misbranding issues. Don't overlook the importance of a pre-launch label review and the role of a U.S. Agent in navigating the regulatory landscape.